These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 32417110)
1. The world is only ten years old: The dawn of artificial intelligence in urologic oncology. Loughlin KR Urol Oncol; 2020 Aug; 38(8):646-649. PubMed ID: 32417110 [No Abstract] [Full Text] [Related]
2. Artificial intelligence in urological oncology: An update and future applications. Brodie A; Dai N; Teoh JY; Decaestecker K; Dasgupta P; Vasdev N Urol Oncol; 2021 Jul; 39(7):379-399. PubMed ID: 34024704 [TBL] [Abstract][Full Text] [Related]
3. Artificial neural networks for decision-making in urologic oncology. Anagnostou T; Remzi M; Lykourinas M; Djavan B Eur Urol; 2003 Jun; 43(6):596-603. PubMed ID: 12767358 [TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence - Changing the Field of Prostate Cancer? Rohan P; O'Reilly MK; Nason GJ Ir Med J; 2020 Mar; 113(3):45. PubMed ID: 32815705 [No Abstract] [Full Text] [Related]
5. Open clinical uro-oncology trials in Canada. Winquist E; Mackenzie MJ; Rodrigues G Can J Urol; 2009 Oct; 16(5):4875-81. PubMed ID: 19796473 [No Abstract] [Full Text] [Related]
6. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction. Lin DW; Shore ND Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074 [No Abstract] [Full Text] [Related]
7. A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval. Haas GP; Scher HI Urol Oncol; 2015 Mar; 33(3):115. PubMed ID: 25620153 [No Abstract] [Full Text] [Related]
8. Open clinical uro-oncology trials in Canada. Mackenzie MJ; Rodrigues G; Winquist E Can J Urol; 2008 Aug; 15(4):4223-8. PubMed ID: 18706156 [No Abstract] [Full Text] [Related]
10. [Active studies of the Working Association for Urological Oncology (AUO) in 2006]. Rexer H Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204 [No Abstract] [Full Text] [Related]
11. The future of quality in urologic oncology: evaluating the horizon of surgical standards. Hampson LA; Brajtbord JS; Meng MV Urol Oncol; 2014 Aug; 32(6):735-40. PubMed ID: 25232559 [No Abstract] [Full Text] [Related]
12. Highlights of the 2008 SUO/SBUR annual meeting: current controversies in urologic oncology. Kibel AS Urol Oncol; 2009; 27(3):293-4. PubMed ID: 19414114 [No Abstract] [Full Text] [Related]
13. 2007 Annual Meeting of the Society of Urologic Oncology and the Society of Basic Urologic Research: Introduction. Mohler JL Urol Oncol; 2009; 27(1):34-5. PubMed ID: 19111795 [No Abstract] [Full Text] [Related]
14. Early experience with Watson for Oncology: a clinical decision-support system for prostate cancer treatment recommendations. Yu SH; Kim MS; Chung HS; Hwang EC; Jung SI; Kang TW; Kwon D World J Urol; 2021 Feb; 39(2):407-413. PubMed ID: 32335733 [TBL] [Abstract][Full Text] [Related]
15. How artificial intelligence could redefine clinical trials in cardiovascular medicine: lessons learned from oncology. Krittanawong C; Johnson KW; Tang WW Per Med; 2019 Mar; 16(2):83-88. PubMed ID: 30838909 [No Abstract] [Full Text] [Related]
16. The hybrid of basic science and clinical training for the urologic oncologist: Necessity or waste? Olumi AF; Dewolf WC Urol Oncol; 2009; 27(2):205-7. PubMed ID: 19285235 [TBL] [Abstract][Full Text] [Related]